MoneyWorks4Me

NATCO Pharma informs about transcript of conference call

04 Jun 2022 Evaluate

NATCO Pharma has informed that it enclosed a copy of the transcript of the Company's earnings conference call for Q4 FY22 held on May 31, 2022. This transcript is also uploaded on its website www.natcopharma.co.in.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..